Weight Management • Fresno, CA
If medication is appropriate, we may discuss GLP-1 therapies such as semaglutide as part of a broader plan— nutrition, movement, sleep, and follow-up that supports lasting change.
Evidence base: FDA (GLP-1 safety info) · STEP 1 Trial (NEJM) · CDC (Obesity)
Metabolic health
Body composition
Long-term sustainability
Private, clinician-guided care designed for real life.
What semaglutide is
Semaglutide as part of comprehensive care
Semaglutide is a prescription medication in the GLP-1 receptor agonist class. Depending on the product and indication, it may be used for type 2 diabetes management and/or chronic weight management in certain adults, alongside lifestyle changes. We determine candidacy based on your medical history, labs, goals, and safety. FDA
Important: We do not position this as “aesthetic enhancement.” Our focus is evidence-based weight and cardiometabolic risk management—safely and responsibly.
- Personalized nutrition + activity plan
- Medication discussion when appropriate
- Ongoing follow-up to support sustainability
What the research shows
Potential outcomes—varies by individual
Weight reduction support
In clinical trials for chronic weight management, semaglutide (with lifestyle intervention) was associated with meaningful weight loss for many participants. STEP 1 (NEJM)
Appetite and satiety
GLP-1 therapies can reduce appetite and increase fullness, which may help support a calorie deficit—when paired with a structured plan. NIDDK
Cardiometabolic focus
Weight management is not just a number. We track blood pressure, glucose markers, lipids, sleep, and energy—building toward long-term risk reduction. CDC
Results and follow-up: Results vary from person to person. Your care plan may include nutrition, movement, sleep, medication when appropriate, and regular follow-up.
The experience
Your weight-management appointments
New to the practice? See what to expect at your first visit.
01
Consult: goals, history, current medications, and prior attempts.
02
Assessment: vitals + labs as appropriate to understand metabolic drivers.
03
Plan: nutrition + movement + sleep strategy; medication options when appropriate.
04
Follow-up: adjust dosing/plan, manage side effects, track progress safely.
Safety & prescribing notes
GLP-1 medications can have side effects and are not appropriate for everyone. Common side effects include gastrointestinal symptoms. There are important warnings and contraindications (including a boxed warning for certain semaglutide products). We review your full history and discuss risks/benefits before prescribing. FDA
Fresno, CA • Private care • Evidence-based approach
Semaglutide & weight management FAQs
Is semaglutide for diabetes or weight loss?
Semaglutide products may be indicated for type 2 diabetes and/or chronic weight management depending on the specific medication and patient criteria. We’ll review what’s appropriate for your medical profile.
Source: FDA
How does it work?
GLP-1 receptor agonists influence appetite and satiety signals, which can help reduce calorie intake when paired with lifestyle changes.
Source: NIDDK
What kind of results should I expect?
Results vary. Clinical trials in chronic weight management showed meaningful average weight loss with semaglutide plus lifestyle intervention for many participants, but individual outcomes differ and follow-up matters.
Source: STEP 1 (NEJM)
Are there side effects or risks?
GLP-1 medications can cause side effects and have warnings/contraindications. We screen carefully, explain risks, and monitor follow-up.
Source: FDA
Do I have to stay on it forever?
That depends on your goals, response, and medical context. We’ll discuss long-term strategy, tapering considerations, and how lifestyle supports maintenance.
Weight management in Fresno, CA
Book an appointment for a calm, structured plan—medication options discussed only when appropriate.
References
1. FDA — GLP-1 safety communications: View
2. Wilding JPH et al. — Semaglutide in adults with overweight/obesity (STEP 1, NEJM 2021): View
3. CDC — Obesity and related health risks: View
4. NIDDK — Overweight & obesity / weight management: View
Educational note: general information only; not individualized medical advice.